Overview

Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This study aims to treat non-elderly adult patients, who were previously untreated for acute myeloid leukemia, using venetoclax and azacitidine.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Azacitidine
Venetoclax